Taken together, our findings revealed that IGF2-AS was a tumor-suppressor, and inhibited tumorigenesis and aggressive behaviors of HCC cells via sponging miR-520h to up-regulate CDKN1A both in vitro and in vivo. This evidence concerns the gene IGF2 and neoplasm.